Europe Radioactive Monoclonal Antibody Market Research Report Forecast 2017-2021

March 2017 | 104 pages | ID: ED4EC284588EN
S&P Consulting

Abstracts

The Europe Radioactive Monoclonal Antibody Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Radioactive Monoclonal Antibody industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Radioactive Monoclonal Antibody market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

Europe Radioactive Monoclonal Antibody Market Analysis by Countries:

Germany
France
UK
Russia
Italy
Spain
Benelux

The Major players reported in the market include:

Pfizer Inc. (USA)
Abbott Laboratories (USA)
Genentech Inc. (USA)
GlaxoSmithKline Plc (UK)
Immunomedics, Inc. (USA)
Indevus Pharmaceuticals Inc. (USA)
Novartis AG (Switzerland)
OSI Pharmaceuticals, Inc. (USA)
Paladin Labs Inc. (Canada)

Europe Radioactive Monoclonal Antibody Market Analysis by Product:

Type 1
Type 2
Type 3

Europe Radioactive Monoclonal Antibody Market Analysis by Application:

Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

1 RADIOACTIVE MONOCLONAL ANTIBODY MARKET OVERVIEW

1.1 Product Overview and Scope of Radioactive Monoclonal Antibody
1.2 Classification of Radioactive Monoclonal Antibody
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Radioactive Monoclonal Antibody
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Radioactive Monoclonal Antibody Market States Status and Prospect (2012-2021) by Countries
  1.4.1 Germany
  1.4.2 France
  1.4.3 UK
  1.4.4 Russia
  1.4.5 Italy
  1.4.6 Spain
  1.4.7 Benelux
1.5 Europe Market Size (Value and Volume) of Radioactive Monoclonal Antibody (2012-2021)
  1.5.1 Europe Radioactive Monoclonal Antibody Sales and Growth Rate (2012-2021)
  1.5.2 Europe Radioactive Monoclonal Antibody Revenue and Growth Rate (2012-2021)

2 EUROPE ECONOMIC IMPACT ON RADIOACTIVE MONOCLONAL ANTIBODY INDUSTRY

2.1 Europe Macroeconomic Analysis
2.2 Europe Macroeconomic Environment Development Trend

3 RADIOACTIVE MONOCLONAL ANTIBODY MANUFACTURING COST ANALYSIS

3.1 Radioactive Monoclonal Antibody Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Radioactive Monoclonal Antibody

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Radioactive Monoclonal Antibody Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Radioactive Monoclonal Antibody Major Manufacturers in 2015
4.4 Downstream Buyers

5 EUROPE RADIOACTIVE MONOCLONAL ANTIBODY MARKET ANALYSIS BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Europe Radioactive Monoclonal Antibody Market Competition by Manufacturers
  5.1.1 Europe Radioactive Monoclonal Antibody Sales and Market Share of Key Manufacturers (2015 and 2016)
  5.1.2 Europe Radioactive Monoclonal Antibody Revenue and Share by Manufacturers (2015 and 2016)
5.2 Europe Radioactive Monoclonal Antibody (Volume and Value) by Type
  5.2.1 Europe Radioactive Monoclonal Antibody Sales and Market Share by Type (2012-2017)
  5.2.2 Europe Radioactive Monoclonal Antibody Revenue and Market Share by Type (2012-2017)
5.3 Europe Radioactive Monoclonal Antibody (Volume and Value) by Countries
  5.3.1 Europe Radioactive Monoclonal Antibody Sales and Market Share by Countries (2012-2017)
  5.3.2 Europe Radioactive Monoclonal Antibody Revenue and Market Share by Countries (2012-2017)
5.4 Europe Radioactive Monoclonal Antibody (Volume) by Application

6 GERMANY RADIOACTIVE MONOCLONAL ANTIBODY (VOLUME, VALUE AND SALES PRICE)

6.1 Germany Radioactive Monoclonal Antibody Sales and Value (2012-2017)
  6.1.1 Germany Radioactive Monoclonal Antibody Sales and Growth Rate (2012-2017)
  6.1.2 Germany Radioactive Monoclonal Antibody Revenue and Growth Rate (2012-2017)
  6.1.3 Germany Radioactive Monoclonal Antibody Sales Price Trend (2012-2017)
6.2 Germany Radioactive Monoclonal Antibody Sales and Market Share by Manufacturers
6.3 Germany Radioactive Monoclonal Antibody Sales and Market Share by Type
6.4 Germany Radioactive Monoclonal Antibody Sales and Market Share by Application

7 FRANCE RADIOACTIVE MONOCLONAL ANTIBODY (VOLUME, VALUE AND SALES PRICE)

7.1 France Radioactive Monoclonal Antibody Sales and Value (2012-2017)
  7.1.1 France Radioactive Monoclonal Antibody Sales and Growth Rate (2012-2017)
  7.1.2 France Radioactive Monoclonal Antibody Revenue and Growth Rate (2012-2017)
  7.1.3 France Radioactive Monoclonal Antibody Sales Price Trend (2012-2017)
7.2 France Radioactive Monoclonal Antibody Sales and Market Share by Manufacturers
7.3 France Radioactive Monoclonal Antibody Sales and Market Share by Type
7.4 France Radioactive Monoclonal Antibody Sales and Market Share by Application

8 UK RADIOACTIVE MONOCLONAL ANTIBODY (VOLUME, VALUE AND SALES PRICE)

8.1 UK Radioactive Monoclonal Antibody Sales and Value (2012-2017)
  8.1.1 UK Radioactive Monoclonal Antibody Sales and Growth Rate (2012-2017)
  8.1.2 UK Radioactive Monoclonal Antibody Revenue and Growth Rate (2012-2017)
  8.1.3 UK Radioactive Monoclonal Antibody Sales Price Trend (2012-2017)
8.2 UK Radioactive Monoclonal Antibody Sales and Market Share by Manufacturers
8.3 UK Radioactive Monoclonal Antibody Sales and Market Share by Type
8.4 UK Radioactive Monoclonal Antibody Sales and Market Share by Application

9 RUSSIA RADIOACTIVE MONOCLONAL ANTIBODY (VOLUME, VALUE AND SALES PRICE)

9.1 Russia Radioactive Monoclonal Antibody Sales and Value (2012-2017)
  9.1.1 Russia Radioactive Monoclonal Antibody Sales and Growth Rate (2012-2017)
  9.1.2 Russia Radioactive Monoclonal Antibody Revenue and Growth Rate (2012-2017)
  9.1.3 Russia Radioactive Monoclonal Antibody Sales Price Trend (2012-2017)
9.2 Russia Radioactive Monoclonal Antibody Sales and Market Share by Manufacturers
9.3 Russia Radioactive Monoclonal Antibody Sales and Market Share by Type
9.4 Russia Radioactive Monoclonal Antibody Sales and Market Share by Application

10 ITALY RADIOACTIVE MONOCLONAL ANTIBODY (VOLUME, VALUE AND SALES PRICE)

10.1 Italy Radioactive Monoclonal Antibody Sales and Value (2012-2017)
  10.1.1 Italy Radioactive Monoclonal Antibody Sales and Growth Rate (2012-2017)
  10.1.2 Italy Radioactive Monoclonal Antibody Revenue and Growth Rate (2012-2017)
  10.1.3 Italy Radioactive Monoclonal Antibody Sales Price Trend (2012-2017)
10.2 Italy Radioactive Monoclonal Antibody Sales and Market Share by Manufacturers
10.3 Italy Radioactive Monoclonal Antibody Sales and Market Share by Type
10.4 Italy Radioactive Monoclonal Antibody Sales and Market Share by Application

11 SPAIN RADIOACTIVE MONOCLONAL ANTIBODY (VOLUME, VALUE AND SALES PRICE)

11.1 Spain Radioactive Monoclonal Antibody Sales and Value (2012-2017)
  11.1.1 Spain Radioactive Monoclonal Antibody Sales and Growth Rate (2012-2017)
  11.1.2 Spain Radioactive Monoclonal Antibody Revenue and Growth Rate (2012-2017)
  11.1.3 Spain Radioactive Monoclonal Antibody Sales Price Trend (2012-2017)
11.2 Spain Radioactive Monoclonal Antibody Sales and Market Share by Manufacturers
11.3 Spain Radioactive Monoclonal Antibody Sales and Market Share by Type
11.4 Spain Radioactive Monoclonal Antibody Sales and Market Share by Application

12 BENELUX RADIOACTIVE MONOCLONAL ANTIBODY (VOLUME, VALUE AND SALES PRICE)

12.1 Benelux Radioactive Monoclonal Antibody Sales and Value (2012-2017)
  12.1.1 Benelux Radioactive Monoclonal Antibody Sales and Growth Rate (2012-2017)
  12.1.2 Benelux Radioactive Monoclonal Antibody Revenue and Growth Rate (2012-2017)
  12.1.3 Benelux Radioactive Monoclonal Antibody Sales Price Trend (2012-2017)
12.2 Benelux Radioactive Monoclonal Antibody Sales and Market Share by Manufacturers
12.3 Benelux Radioactive Monoclonal Antibody Sales and Market Share by Type
12.4 Benelux Radioactive Monoclonal Antibody Sales and Market Share by Application

13 EUROPE RADIOACTIVE MONOCLONAL ANTIBODY MANUFACTURERS ANALYSIS

13.1 Pfizer Inc. (USA)
  13.1.1 Company Basic Information, Manufacturing Base and Competitors
  13.1.2 Product Type, Application and Specification
  13.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.1.4 Business Overview
13.2 Abbott Laboratories (USA)
  13.2.1 Company Basic Information, Manufacturing Base and Competitors
  13.2.2 Product Type, Application and Specification
  13.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.2.4 Business Overview
13.3 Genentech Inc. (USA)
  13.3.1 Company Basic Information, Manufacturing Base and Competitors
  13.3.2 Product Type, Application and Specification
  13.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.3.4 Business Overview
13.4 GlaxoSmithKline Plc (UK)
  13.4.1 Company Basic Information, Manufacturing Base and Competitors
  13.4.2 Product Type, Application and Specification
  13.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.4.4 Business Overview
13.5 Immunomedics, Inc. (USA)
  13.5.1 Company Basic Information, Manufacturing Base and Competitors
  13.5.2 Product Type, Application and Specification
  13.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.5.4 Business Overview
13.6 Indevus Pharmaceuticals Inc. (USA)
  13.6.1 Company Basic Information, Manufacturing Base and Competitors
  13.6.2 Product Type, Application and Specification
  13.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.6.4 Business Overview
13.7 Novartis AG (Switzerland)
  13.7.1 Company Basic Information, Manufacturing Base and Competitors
  13.7.2 Product Type, Application and Specification
  13.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.7.4 Business Overview
13.8 OSI Pharmaceuticals, Inc. (USA)
  13.8.1 Company Basic Information, Manufacturing Base and Competitors
  13.8.2 Product Type, Application and Specification
  13.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.8.4 Business Overview
13.9 Paladin Labs Inc. (Canada)
  13.9.1 Company Basic Information, Manufacturing Base and Competitors
  13.9.2 Product Type, Application and Specification
  13.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.9.4 Business Overview

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 EUROPE RADIOACTIVE MONOCLONAL ANTIBODY MARKET FORECAST (2017-2021)

15.1 Germany Market Forecast (2017-2021)
15.2 France Market Forecast (2017-2021)
15.3 UK Market Forecast (2017-2021)
15.4 Russia Market Forecast (2017-2021)
15.5 Italy Market Forecast (2017-2021)
15.6 Spain Market Forecast (2017-2021)
15.7 Benelux Market Forecast (2017-2021)
15.8 Europe Radioactive Monoclonal Antibody Market Forecast by Type (2017-2021)
15.9 Europe Radioactive Monoclonal Antibody Market Forecast by Application (2017-2021)

16 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Radioactive Monoclonal Antibody
Table Classification of Radioactive Monoclonal Antibody
Figure Europe Sales Market Share of Radioactive Monoclonal Antibody by Type in 2015
Table Application of Radioactive Monoclonal Antibody
Figure Europe Sales Market Share of Radioactive Monoclonal Antibody by Application in 2015
Figure Germany Radioactive Monoclonal Antibody Revenue and Growth Rate (2012-2021)
Figure France Radioactive Monoclonal Antibody Revenue and Growth Rate (2012-2021)
Figure UK Radioactive Monoclonal Antibody Revenue and Growth Rate (2012-2021)
Figure Russia Radioactive Monoclonal Antibody Revenue and Growth Rate (2012-2021)
Figure Italy Radioactive Monoclonal Antibody Revenue and Growth Rate (2012-2021)
Figure Spain Radioactive Monoclonal Antibody Revenue and Growth Rate (2012-2021)
Figure Benelux Radioactive Monoclonal Antibody Revenue and Growth Rate (2012-2021)
Figure Europe Radioactive Monoclonal Antibody Sales and Growth Rate (2012-2021)
Figure Europe Radioactive Monoclonal Antibody Revenue and Growth Rate (2012-2021)
Table Europe Radioactive Monoclonal Antibody Sales of Key Manufacturers (2015 and 2016)
Table Europe Radioactive Monoclonal Antibody Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Radioactive Monoclonal Antibody Sales Share by Manufacturers
Figure 2016 Radioactive Monoclonal Antibody Sales Share by Manufacturers
Table Europe Radioactive Monoclonal Antibody Revenue by Manufacturers (2015 and 2016)
Table Europe Radioactive Monoclonal Antibody Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Radioactive Monoclonal Antibody Revenue Share by Manufacturers
Table 2016 Europe Radioactive Monoclonal Antibody Revenue Share by Manufacturers
Table Europe Radioactive Monoclonal Antibody Sales and Market Share by Type (2012-2017)
Table Europe Radioactive Monoclonal Antibody Sales Share by Type (2012-2017)
Figure Sales Market Share of Radioactive Monoclonal Antibody by Type (2012-2017)
Figure Europe Radioactive Monoclonal Antibody Sales Growth Rate by Type (2012-2017)
Table Europe Radioactive Monoclonal Antibody Revenue and Market Share by Type (2012-2017)
Table Europe Radioactive Monoclonal Antibody Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Radioactive Monoclonal Antibody by Type (2012-2017)
Figure Europe Radioactive Monoclonal Antibody Revenue Growth Rate by Type (2012-2017)
Table Europe Radioactive Monoclonal Antibody Sales and Market Share by Countries (2012-2017)
Table Europe Radioactive Monoclonal Antibody Sales Share by Countries (2012-2017)
Figure Sales Market Share of Radioactive Monoclonal Antibody by Countries (2012-2017)
Table Europe Radioactive Monoclonal Antibody Revenue and Market Share by Countries (2012-2017)
Table Europe Radioactive Monoclonal Antibody Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Radioactive Monoclonal Antibody by Countries (2012-2017)
Table Europe Radioactive Monoclonal Antibody Sales and Market Share by Application (2012-2017)
Table Europe Radioactive Monoclonal Antibody Sales Share by Application (2012-2017)
Figure Sales Market Share of Radioactive Monoclonal Antibody by Application (2012-2017)
Figure Germany Radioactive Monoclonal Antibody Sales and Growth Rate (2012-2017)
Figure Germany Radioactive Monoclonal Antibody Revenue and Growth Rate (2012-2017)
Figure Germany Radioactive Monoclonal Antibody Sales Price Trend (2012-2017)
Table Germany Radioactive Monoclonal Antibody Sales by Manufacturers (2015 and 2016)
Table Germany Radioactive Monoclonal Antibody Market Share by Manufacturers (2015 and 2016)
Table Germany Radioactive Monoclonal Antibody Sales by Type (2015 and 2016)
Table Germany Radioactive Monoclonal Antibody Market Share by Type (2015 and 2016)
Table Germany Radioactive Monoclonal Antibody Sales by Application (2015 and 2016)
Table Germany Radioactive Monoclonal Antibody Market Share by Application (2015 and 2016)
Figure France Radioactive Monoclonal Antibody Sales and Growth Rate (2012-2017)
Figure France Radioactive Monoclonal Antibody Revenue and Growth Rate (2012-2017)
Figure France Radioactive Monoclonal Antibody Sales Price Trend (2012-2017)
Table France Radioactive Monoclonal Antibody Sales by Manufacturers (2015 and 2016)
Table France Radioactive Monoclonal Antibody Market Share by Manufacturers (2015 and 2016)
Table France Radioactive Monoclonal Antibody Sales by Type (2015 and 2016)
Table France Radioactive Monoclonal Antibody Market Share by Type (2015 and 2016)
Table France Radioactive Monoclonal Antibody Sales by Application (2015 and 2016)
Table France Radioactive Monoclonal Antibody Market Share by Application (2015 and 2016)
Figure UK Radioactive Monoclonal Antibody Sales and Growth Rate (2012-2017)
Figure UK Radioactive Monoclonal Antibody Revenue and Growth Rate (2012-2017)
Figure UK Radioactive Monoclonal Antibody Sales Price Trend (2012-2017)
Table UK Radioactive Monoclonal Antibody Sales by Manufacturers (2015 and 2016)
Table UK Radioactive Monoclonal Antibody Market Share by Manufacturers (2015 and 2016)
Table UK Radioactive Monoclonal Antibody Sales by Type (2015 and 2016)
Table UK Radioactive Monoclonal Antibody Market Share by Type (2015 and 2016)
Table UK Radioactive Monoclonal Antibody Sales by Application (2015 and 2016)
Table UK Radioactive Monoclonal Antibody Market Share by Application (2015 and 2016)
Figure Russia Radioactive Monoclonal Antibody Sales and Growth Rate (2012-2017)
Figure Russia Radioactive Monoclonal Antibody Revenue and Growth Rate (2012-2017)
Figure Russia Radioactive Monoclonal Antibody Sales Price Trend (2012-2017)
Table Russia Radioactive Monoclonal Antibody Sales by Manufacturers (2015 and 2016)
Table Russia Radioactive Monoclonal Antibody Market Share by Manufacturers (2015 and 2016)
Table Russia Radioactive Monoclonal Antibody Sales by Type (2015 and 2016)
Table Russia Radioactive Monoclonal Antibody Market Share by Type (2015 and 2016)
Table Russia Radioactive Monoclonal Antibody Sales by Application (2015 and 2016)
Table Russia Radioactive Monoclonal Antibody Market Share by Application (2015 and 2016)
Figure Italy Radioactive Monoclonal Antibody Sales and Growth Rate (2012-2017)
Figure Italy Radioactive Monoclonal Antibody Revenue and Growth Rate (2012-2017)
Figure Italy Radioactive Monoclonal Antibody Sales Price Trend (2012-2017)
Table Italy Radioactive Monoclonal Antibody Sales by Manufacturers (2015 and 2016)
Table Italy Radioactive Monoclonal Antibody Market Share by Manufacturers (2015 and 2016)
Table Italy Radioactive Monoclonal Antibody Sales by Type (2015 and 2016)
Table Italy Radioactive Monoclonal Antibody Market Share by Type (2015 and 2016)
Table Italy Radioactive Monoclonal Antibody Sales by Application (2015 and 2016)
Table Italy Radioactive Monoclonal Antibody Market Share by Application (2015 and 2016)
Figure Spain Radioactive Monoclonal Antibody Sales and Growth Rate (2012-2017)
Figure Spain Radioactive Monoclonal Antibody Revenue and Growth Rate (2012-2017)
Figure Spain Radioactive Monoclonal Antibody Sales Price Trend (2012-2017)
Table Spain Radioactive Monoclonal Antibody Sales by Manufacturers (2015 and 2016)
Table Spain Radioactive Monoclonal Antibody Market Share by Manufacturers (2015 and 2016)
Table Spain Radioactive Monoclonal Antibody Sales by Type (2015 and 2016)
Table Spain Radioactive Monoclonal Antibody Market Share by Type (2015 and 2016)
Table Spain Radioactive Monoclonal Antibody Sales by Application (2015 and 2016)
Table Spain Radioactive Monoclonal Antibody Market Share by Application (2015 and 2016)
Figure Benelux Radioactive Monoclonal Antibody Sales and Growth Rate (2012-2017)
Figure Benelux Radioactive Monoclonal Antibody Revenue and Growth Rate (2012-2017)
Figure Benelux Radioactive Monoclonal Antibody Sales Price Trend (2012-2017)
Table Benelux Radioactive Monoclonal Antibody Sales by Manufacturers (2015 and 2016)
Table Benelux Radioactive Monoclonal Antibody Market Share by Manufacturers (2015 and 2016)
Table Benelux Radioactive Monoclonal Antibody Sales by Type (2015 and 2016)
Table Benelux Radioactive Monoclonal Antibody Market Share by Type (2015 and 2016)
Table Benelux Radioactive Monoclonal Antibody Sales by Application (2015 and 2016)
Table Benelux Radioactive Monoclonal Antibody Market Share by Application (2015 and 2016)
Table Pfizer Inc. (USA) Basic Information List
Table Pfizer Inc. (USA) Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Inc. (USA) Radioactive Monoclonal Antibody Sales Market Share (2012-2017)
Table Abbott Laboratories (USA) Basic Information List
Table Abbott Laboratories (USA) Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Table Abbott Laboratories (USA) Radioactive Monoclonal Antibody Sales Market Share (2012-2017)
Table Genentech Inc. (USA) Basic Information List
Table Genentech Inc. (USA) Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Genentech Inc. (USA) Radioactive Monoclonal Antibody Sales Market Share (2012-2017)
Table GlaxoSmithKline Plc (UK) Basic Information List
Table GlaxoSmithKline Plc (UK) Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Plc (UK) Radioactive Monoclonal Antibody Sales Market Share (2012-2017)
Table Immunomedics, Inc. (USA) Basic Information List
Table Immunomedics, Inc. (USA) Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Immunomedics, Inc. (USA) Radioactive Monoclonal Antibody Sales Market Share (2012-2017)
Table Indevus Pharmaceuticals Inc. (USA) Basic Information List
Table Indevus Pharmaceuticals Inc. (USA) Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Table Indevus Pharmaceuticals Inc. (USA) Radioactive Monoclonal Antibody Sales Market Share (2012-2017)
Table Novartis AG (Switzerland) Basic Information List
Table Novartis AG (Switzerland) Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis AG (Switzerland) Radioactive Monoclonal Antibody Sales Market Share (2012-2017)
Table OSI Pharmaceuticals, Inc. (USA) Basic Information List
Table OSI Pharmaceuticals, Inc. (USA) Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Table OSI Pharmaceuticals, Inc. (USA) Radioactive Monoclonal Antibody Sales Market Share (2012-2017)
Table Paladin Labs Inc. (Canada) Basic Information List
Table Paladin Labs Inc. (Canada) Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Paladin Labs Inc. (Canada) Radioactive Monoclonal Antibody Sales Market Share (2012-2017).
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Radioactive Monoclonal Antibody
Figure Manufacturing Process Analysis of Radioactive Monoclonal Antibody
Figure Radioactive Monoclonal Antibody Industrial Chain Analysis
Table Raw Materials Sources of Radioactive Monoclonal Antibody Major Manufacturers in 2015
Table Major Buyers of Radioactive Monoclonal Antibody
Table Distributors/Traders List
Figure Germany Radioactive Monoclonal Antibody Sales and Growth Rate Forecast (2017-2021)
Figure Germany Radioactive Monoclonal Antibody Revenue and Growth Rate Forecast (2017-2021)
Figure France Radioactive Monoclonal Antibody Sales and Growth Rate Forecast (2017-2021)
Figure France Radioactive Monoclonal Antibody Revenue and Growth Rate Forecast (2017-2021)
Figure UK Radioactive Monoclonal Antibody Sales and Growth Rate Forecast (2017-2021)
Figure UK Radioactive Monoclonal Antibody Revenue and Growth Rate Forecast (2017-2021)
Figure Russia Radioactive Monoclonal Antibody Sales and Growth Rate Forecast (2017-2021)
Figure Russia Radioactive Monoclonal Antibody Revenue and Growth Rate Forecast (2017-2021)
Figure Italy Radioactive Monoclonal Antibody Sales and Growth Rate Forecast (2017-2021)
Figure Italy Radioactive Monoclonal Antibody Revenue and Growth Rate Forecast (2017-2021)
Figure Spain Radioactive Monoclonal Antibody Sales and Growth Rate Forecast (2017-2021)
Figure Spain Radioactive Monoclonal Antibody Revenue and Growth Rate Forecast (2017-2021)
Figure Benelux Radioactive Monoclonal Antibody Sales and Growth Rate Forecast (2017-2021)
Figure Benelux Radioactive Monoclonal Antibody Revenue and Growth Rate Forecast (2017-2021)
Table Europe Radioactive Monoclonal Antibody Sales Forecast by Type (2017-2021)
Table Europe Radioactive Monoclonal Antibody Sales Forecast by Application (2017-2021)